menu
    • menu

    Company profile for Ascentage Pharma

    NEW Drugs in Dev: 13
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Leveraging our expertise in structure-based drug design and our innovative drug discovery engine, we have developed a robust pipeline of seven drug candidates that disrupt complex and difficult-to-target protein-protein interactions (PPIs), and next-genera...
    Ascentage Pharma is a globally-focused, clinical-stage biopharmaceutical company developing novel small molecule therapies for cancers, hepatitis B and age-related diseases. Leveraging our expertise in structure-based drug design and our innovative drug discovery engine, we have developed a robust pipeline of seven drug candidates that disrupt complex and difficult-to-target protein-protein interactions (PPIs), and next-generation tyrosine kinase inhibitors (TKIs).

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Ascentage PharmaChina Flag
    Country
    Country
    China
    Address
    Address
    218 Xinghu Street, Building B7, 7th Floor, Suzhou Industrial Park, Suzhou, Jia...
    Telephone
    Telephone
    +86-512-85557777
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ascentagepharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/ascentage-pharma-group-corporation
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ascentage Pharma Shares Innovation Strategy at J.P. Morgan Conf
    Ascentage Pharma Shares Innovation Strategy at J.P. Morgan Conf

    14 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/15/3219202/0/en/Ascentage-Pharma-Outlined-its-Global-Innovation-Strategy-During-Presentation-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    14 Jan 2026
    Share Share
    Ascentage Pharma at 44th J.P. Morgan Healthcare Conference
    Ascentage Pharma at 44th J.P. Morgan Healthcare Conference

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3206945/0/en/Ascentage-Pharma-to-Present-at-44th-Annual-J-P-Morgan-Healthcare-Conference.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    In Diagnosed Ph+ ALL, Olverembatinib Yields >60% MRD-Neg CR Rate
    In Diagnosed Ph+ ALL, Olverembatinib Yields >60% MRD-Neg CR Rate

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202021/0/en/ASH-2025-Ascentage-Pharma-Presents-First-Dataset-from-Phase-III-POLARIS-1-Study-of-Olverembatinib-in-Newly-Diagnosed-Ph-ALL-Shows-a-Best-MRD-Negativity-CR-Rate-Exceeding-60.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Ascentage Pharma Reveals 4-Year Data On Olverembatinib
    Ascentage Pharma Reveals 4-Year Data On Olverembatinib

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202022/0/en/ASH-2025-Ascentage-Pharma-Presents-Four-Year-Follow-Up-Data-from-Registrational-Phase-II-Study-of-Olverembatinib-Reaffirming-Differentiated-Long-Term-Efficacy-and-Safety-in-TKI-Res.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Ascentage Pharma Update Olverembatinib Data In 2nd-Line Treatment
    Ascentage Pharma Update Olverembatinib Data In 2nd-Line Treatment

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/09/3202020/0/en/ASH-2025-Updated-Data-for-Ascentage-Pharma-s-Olverembatinib-in-Second-Line-CML-CP-Showing-Encouraging-Potential-for-Early-Line-Treatment.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Ascentage Pharma Reveals Positive Results From Lisaftoclax Study
    Ascentage Pharma Reveals Positive Results From Lisaftoclax Study

    07 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201167/0/en/ASH-2025-Ascentage-Pharma-Presents-Encouraging-Data-from-Phase-Ib-II-Study-of-Bcl-2-Inhibitor-Lisaftoclax-in-Venetoclax-Exposed-Patients-with-Myeloid-Malignances.html

    GLOBENEWSWIRE
    07 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search